| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc. | Birznieks Gunther | SVP, Business Development | Mar 04, 2024 | Sale | $4.30 | 8,727 | 37,495 | 322,253 | Mar 06, 2024, 04:46 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Birznieks Gunther | SVP, Business Development | Mar 05, 2024 | Sale | $4.13 | 8,684 | 35,884 | 313,569 | Mar 06, 2024, 04:46 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Birznieks Gunther | SVP, Business Development | Mar 02, 2023 | Sale | $6.20 | 8,509 | 52,793 | 214,248 | Mar 06, 2023, 06:24 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Birznieks Gunther | SVP, Business Development | Mar 03, 2023 | Sale | $6.26 | 8,268 | 51,791 | 205,980 | Mar 06, 2023, 06:24 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Birznieks Gunther | SVP, Business Development | Aug 26, 2022 | Option Exercise | $3.12 | 1,250 | 3,900 | 190,057 | Aug 29, 2022, 05:02 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Birznieks Gunther | SVP, Business Development | Mar 01, 2022 | Sale | $11.19 | 4,084 | 45,700 | 200,324 | Mar 02, 2022, 09:26 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Birznieks Gunther | SVP, Business Development | Mar 02, 2022 | Sale | $11.27 | 11,517 | 129,792 | 188,807 | Mar 02, 2022, 09:26 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Birznieks Gunther | SVP, Business Development | Mar 01, 2021 | Sale | $18.66 | 3,845 | 71,744 | 188,328 | Mar 03, 2021, 06:39 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Birznieks Gunther | SVP, Business Development | Mar 02, 2021 | Sale | $18.19 | 16,620 | 302,273 | 171,708 | Mar 03, 2021, 06:39 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Birznieks Gunther | SVP, Business Development | Mar 02, 2020 | Sale | $10.04 | 12,223 | 122,686 | 165,008 | Mar 04, 2020, 05:00 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Birznieks Gunther | SVP, Business Development | Mar 03, 2020 | Sale | $10.66 | 5,535 | 58,984 | 159,473 | Mar 04, 2020, 05:00 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Birznieks Gunther | SVP, Business Development | Jan 02, 2020 | Sale | $15.93 | 4,020 | 64,021 | 147,231 | Jan 06, 2020, 05:25 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Birznieks Gunther | SVP, Business Development | Mar 01, 2019 | Sale | $20.14 | 3,741 | 75,325 | 160,039 | Mar 04, 2019, 12:00 AM | |
| VNDA | Vanda Pharmaceuticals Inc. | Birznieks Gunther | SVP, Business Development | Mar 04, 2019 | Sale | $19.89 | 8,788 | 174,767 | 151,251 | Mar 04, 2019, 12:00 AM | |
| VNDA | Vanda Pharmaceuticals Inc. | Birznieks Gunther | SVP, Business Development | Jan 02, 2019 | Sale | $26.47 | 4,442 | 117,578 | 136,569 | Jan 04, 2019, 04:34 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Birznieks Gunther | SVP, Business Development | Jan 03, 2019 | Sale | $26.08 | 1,619 | 42,232 | 133,780 | Jan 04, 2019, 04:34 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Birznieks Gunther | SVP, Business Development | Mar 01, 2018 | Sale | $18.72 | 8,525 | 159,605 | 139,841 | Mar 02, 2018, 05:32 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Birznieks Gunther | SVP, Business Development | Jan 02, 2018 | Sale | $15.26 | 8,568 | 130,777 | 118,366 | Jan 04, 2018, 05:09 PM |
Menu